EPA Settlement With States Closes Loopholes That Allowed Companies to Avoid Asbestos Reporting Requirements

The U.S. Environmental Protection Agency (EPA) has reached a settlement with several states, agreeing to close loopholes which previously allowed companies to avoid reporting the use of toxic asbestos substances.

The settlement agreement (PDF) was announced earlier this month between the EPA, California, Massachusetts, Connecticut, Hawaii, Maine, Maryland, Minnesota, New Jersey, Oregon, Washington and D.C., as well as with several organizations and non-profits, including the Asbestos Disease Awareness Organization, the American Public Health Association, the Center for Environmental Health, the Environmental Working Group, the Environmental Health Strategy Center and Safer Chemicals Health Families. It is a result of a lawsuit brought by the states and organizations in June 2019.

In the settlement, the EPA agreed to propose a new rule to collect data on exemptions for the use of asbestos and then eliminate those exemptions. The EPA has agreed to meet specific deadlines that require it to propose the new rule no later than nine months after the settlement is approved, and a final rule no later than 18 months after approval.

Learn More About

Mesothelioma Lawsuits

Exposure to asbestos can cause the development of mesothelioma. Lawsuits have been filed nationwide against asbestos manufacturers.

Learn More SEE IF YOU QUALIFY FOR COMPENSATION

The accord comes in the wake of a December 2020 ruling by U.S. District Judge Edward Chen of the Northern District of California, which ordered the EPA to collect better data on the use, manufacture and import of asbestos into the United States.

The risks of asbestos exposure, which can cause lung cancer, asbestosis, mesothelioma and other serious health injuries, have been known for about a century, although they did not get widely publicized until 1964. Most modern, first-world countries banned asbestos use in its entirety decades ago. But not the United States.

Despite the ban on most applications, about 750 metric tons of asbestos are used in the United States every year. The EPA was given a chance to ban asbestos again in 2016, as part of a new chemical safety law meant to require safety reviews of key chemicals, but refused.

The EPA again refused to put an outright ban on asbestos in place in April 2019, as part of a significant new use rule. That decision came amid public comments by doctors, health experts and consumers who supported a ban.

In May 2019, The New York Times published internal memos showing even the EPA’s own experts were against the decision and thought remaining asbestos uses should be banned. At the time, EPA personnel objected to claims that “new uses” of asbestos could be safer, of narrow definitions of what asbestos is, and also complained that the EPA was only considering lung cancer and mesothelioma as potential asbestos harms.

“The long-time failure of the EPA to regulate asbestos is an environmental injustice and public health tragedy,” California Attorney General Rob Bonta said in a press release. “As with so many environmental toxins, it is our low-income communities, communities of color, and young children who are disproportionately exposed to this deadly carcinogen and who suffer the resulting health consequences. Today’s commitment by the Biden Administration’s EPA to collect missing information about the import and use of asbestos is an important step toward ensuring all Americans live in a community that is healthy and safe.”

The press release indicates asbestos-related illnesses cause 15,000 deaths per year in the U.S. Those illnesses can include mesothelioma, fibrosis, lung cancer, gastrointestinal cancer, asbestosis and other diseases.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California
Generic Depo-Provera Manufacturers Call for Birth Control Shot MDL to Be Created in NY, Not California (Posted 2 days ago)

A growing number of lawsuits against generic Depo-Provera manufacturers have been filed throughout the federal court system, each alleging that women were not adequately warned about the risk of meningioma brain tumors from the birth control shot.

Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024
Oxbryta Class Action Lawsuit Filed by Former Users of Sickle Cell Disease Drug Recalled in 2024 (Posted 3 days ago)

Former users of the recalled sickle cell disease drug Oxbryta have filed a class action lawsuit, claiming the manufacturer failed to warn consumers about risks associated with the medication, which can result in stroke and death.